Caribou Biosciences share price logo

Caribou Biosciences Share Price

NASDAQ: CRBU

Small Cap

$1.90

(+-0.14%)

as on

Caribou Biosciences Stock Performance

as on December 9, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $1.86
    $1.96
    downward going graph

    2.11%

    Downside

    3.16%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.66
    $3.54
    downward going graph

    65.26%

    Downside

    86.05%

    Upside

    downward going graph

Caribou Biosciences share price movements today

Previous Close
$1.90
Open
$1.93
Volume
1.3M
Day's Low - High
$1.86 - $1.96
52 Week Low - High
$0.66 - $3.54

Caribou Biosciences Historical Returns

1 Month Return
-9.57 %
3 Month Return
+ 2.72 %
1 Year Return
-11.68 %
3 Year Return
-78.93 %
5 Year Return
0 %

Caribou Biosciences Stock Fundamentals & Key Indicators

Check Caribou Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$177.6M

EPS (TTM)

-1.5943

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.54

Industry PE ratio

-0.4116938110749186

PEG Ratio

0

EBITDA

-135.7M

Revenue (TTM)

9.3M

Profit Margin

0.00%

Return On Equity TTM

-74.28%

Caribou Biosciences Stock Valuation

Track how Caribou Biosciences P/E has moved over time to understand its valuation trends.

Caribou Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-6.17x)

September 30, 2022

Today (-1.54x)

December 9, 2025

Industry (-0.41x)

December 9, 2025

Highest (-0.63x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.54x

Caribou Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caribou Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Caribou Biosciences image
Caribou Biosciences
BUY$177.6MNA-1.540.00%
Insmed Incorporated image
Insmed Incorporated
BUY$41.9B390.27%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B246.68%1431.621.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.8B97.01%32.0531.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$76.1B43.92%17.2132.13%

Stock Returns calculator for Caribou Biosciences Stock including INR - Dollar returns

The Caribou Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Caribou Biosciences investment value today

Current value as on today

₹94,924

Returns

₹5,076

(-5.08%)

Returns from Caribou Biosciences Stock

₹11,215 (-11.21%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Caribou Biosciences Stock

Based on 15 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Caribou Biosciences. Average target price of $11.12

Caribou Biosciences Share Price Target

Get share price movements and forecasts by analysts on Caribou Biosciences.

What analysts predicted

82.91%UPSIDE

Target Price

$11.12

Current Price

$1.9

Analyzed by

15 Analysts

Target

$11.12

Caribou Biosciences target price $11.12, a slight upside of 82.91% compared to current price of $1.9. According to 15 analysts rating.

Caribou Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
3
23
3
2
3
2
2
2
2
2
Gross Profit
-22
-4
1
1
2
2
-27
2
2
1
Operating Income
-32
-14
-37
-46
-43
-38
-38
-42
-47
-29
EBITDA
-32
-13
-36
-45
-42
-37
-37
-41
-34
-26
Interest Expense
-
-
3
-
-
-
-
-
-
-
Depreciation
0
1
0
0
0
1
1
1
1
0
Income Before Tax
-29
-10
-34
-41
-37
-34
-35
-39
-54
-27
Income Tax Expense
0
-3
0
0
-
-
0
-
-
-
Net Income
-29
-10
-34
-41
-37
-34
-35
-39
-54
-27
Net Profit Margin
-786.13%
-42.27%
-969.79%
-1697.57%
-1088.25%
-1713.64%
-1708.71%
-1699.58%
-2028.42%
-1253.32%

Caribou Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
5
12
9
13
34
9
Gross Profit
5
-22
8
10
30
6
Operating Income
-34
-36
-66
-106
-116
-166
EBITDA
-30
-35
-65
-95
-112
-162
Interest Expense
0
0
0
8
-
-
Depreciation
0
0
0
1
3
3
Income Before Tax
-30
-36
-66
-99
-101
-149
Income Tax Expense
-7
-1
0
0
0
0
Net Income
-23
-34
-66
-99
-102
-149
Net Profit Margin
-404.82%
-277.55%
-697.26%
-717.79%
-296.05%
-1491.95%

Caribou Biosciences Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-10
-34
-41
-37
-34
-35
-39
-54
-27
Operating Cash Flow
-28
-21
-37
-32
-32
-35
-36
-28
-25
Investing Cash Flow
-68
-31
22
21
26
15
49
24
10
Financing Cash Flow
135
0
12
0
0
3
0
0
0
Change in Cash
37
-52
-1
-11
-5
-15
13
-4
-14

Caribou Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-34
-66
-99
-102
-149
Operating Cash Flow
-33
-32
-90
-93
-138
Investing Cash Flow
6
-176
-93
-68
86
Financing Cash Flow
1
433
2
154
16
Change in Cash
-25
224
-182
-7
-34

Global Institutional Holdings in Caribou Biosciences

Funds
Holdings
Pfizer Inc
5.04%
Vanguard Group Inc
4.39%
Kynam Capital Management, LP
3.29%
Schonfeld Strategic Advisors LLC
2.44%
BlackRock Inc
2.02%
See all

Insights on Caribou Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -54.09M → -27.54M (in $), with an average increase of 96.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CRBU stock has moved up by 8.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 180.3% return, outperforming this stock by 191.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 1005.1% return, outperforming this stock by 1083.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.66M → 2.19M (in $), with an average decrease of 17.6% per quarter

About Caribou Biosciences

caribou biosciences is a leading biotechnology company in genome engineering. we develop technology-based solutions for cellular engineering and analysis based on the crispr-cas9 technology platform. cas9, when paired with a guide rna, cuts double-stranded dna allowing for specific changes to dna. these site-specific dna modifications can be utilized to carry out sophisticated gene knock-outs or knock-ins. caribou's technologies mark a revolutionary development that allows scientists to engineer nearly any part of any genome with extreme flexibility. forbes magazine has called cas9 the protein that "could change biotech forever"​ and the new york times has noted that "the pace of new discoveries and applications is dizzying."​ caribou's tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. interested in joining our team? please contact us at jobs at cariboub
OrganisationCaribou Biosciences
Headquarters2929 7th Street, Berkeley, CA, United States, 94710
IndustryServices
CEODr. Rachel E. Haurwitz Ph.D.
E-voting on sharesClick here to vote

Key Management of Caribou Biosciences

Name

Title

Mr. Daniel Poon

Vice President of Operations & Information Technology

Mr. Timothy P. Kelly M.B.A.

Chief Technology Officer

Ms. Barbara G. McClung Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Sriram Ryali M.B.A.

Chief Financial Officer

Mr. Ryan Fischesser

Interim Principal Accounting Officer & Controller

Ms. Amy Figueroa C.F.A.

Vice President of Investor Relations & Corporate Communications

Ms. Reigin Zawadzki

Chief People Officer

Ms. Ruhi A. Khan M.B.A.

Chief Business Officer

Dr. Rachel E. Haurwitz Ph.D.

Co-Founder, CEO, President & Director

Dr. Tina Albertson M.D., Ph.D.

Chief Medical Officer

FAQs

What is Caribou Biosciences share price today?

Caribou Biosciences share price today is $1.9 as on at the close of the market. Caribou Biosciences share today touched a day high of $1.96 and a low of $1.86.

What is the 52 week high and 52 week low for Caribou Biosciences share?

Caribou Biosciences share touched a 52 week high of $3.54 on and a 52 week low of $0.66 on . Caribou Biosciences stock price today i.e. is closed at $1.9,which is 46.25% down from its 52 week high and 187.88% up from its 52 week low.

What is Caribou Biosciences's market capitalisation today?

Caribou Biosciences market capitalisation is $0.00T as on .

How to invest in Caribou Biosciences Stock (CRBU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Caribou Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Caribou Biosciences Shares that will get you 0.7895 shares as per Caribou Biosciences share price of $1.9 per share as on December 9, 2025 at 2:29 am IST.

What is the minimum amount required to buy Caribou Biosciences Stock (CRBU) from India?

Indian investors can start investing in Caribou Biosciences (CRBU) shares with as little as ₹90.066 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Caribou Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Caribou Biosciences share’s latest price of $1.9 as on December 9, 2025 at 2:29 am IST, you will get 5.2632 shares of Caribou Biosciences. Learn more about fractional shares .